Related Articles
KBH-A42, a histone deacetylase inhibitor, inhibits the growth of doxorubicin-resistant leukemia cells expressing P-glycoprotein
Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer
Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1
Biomarkers for predicting response to tyrosine kinase inhibitors in drug-sensitive and drug-resistant human bladder cancer cells
An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer